drugset / Trial / NCT05476900
A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the efficacy and safety of HR19042 capsules for the treatment of autoimmune hepatitis. It will also explore the optimal frequency and dosage of HR19042 capsules administration for the treatment.
Timeline
- Start
- 2022-10-06
- Primary completion
- 2025-03-14
- Completion
- 2025-03-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HR19042 | Unknown | 4 mg | — |
| Subject | HR19042 | Unknown | 8 mg | — |
| Subject | HR19042 | Unknown | 12 mg | — |